Johnson Matthey (LON:JMAT) Given New GBX 2,120 Price Target at Deutsche Bank Aktiengesellschaft

Johnson Matthey (LON:JMATFree Report) had its price target raised by Deutsche Bank Aktiengesellschaft from GBX 1,922 to GBX 2,120 in a research note released on Tuesday morning,London Stock Exchange reports. The firm currently has a buy rating on the stock.

Separately, Berenberg Bank lowered their price target on shares of Johnson Matthey from GBX 2,250 to GBX 2,100 and set a “buy” rating for the company in a report on Monday, March 23rd. Four analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of GBX 2,222.

Read Our Latest Stock Report on JMAT

Johnson Matthey Stock Down 0.2%

Shares of LON:JMAT opened at GBX 1,918 on Tuesday. The company has a fifty day moving average of GBX 2,067.80 and a 200-day moving average of GBX 2,105.42. The company has a market capitalization of £3.21 billion, a PE ratio of -29.10, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.96. The company has a debt-to-equity ratio of 71.01, a quick ratio of 0.76 and a current ratio of 1.65. Johnson Matthey has a 52-week low of GBX 1,138 and a 52-week high of GBX 2,434.

Insider Buying and Selling

In other Johnson Matthey news, insider Liam Condon acquired 14 shares of Johnson Matthey stock in a transaction that occurred on Wednesday, March 11th. The shares were bought at an average price of GBX 1,941 per share, with a total value of £271.74. Also, insider Andrew Cosslett acquired 5,136 shares of Johnson Matthey stock in a transaction that occurred on Tuesday, February 24th. The stock was acquired at an average cost of GBX 1,937 per share, for a total transaction of £99,484.32. Insiders have acquired a total of 10,430 shares of company stock valued at $20,146,398 over the last 90 days. 0.51% of the stock is owned by insiders.

Johnson Matthey Company Profile

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.

Featured Stories

Analyst Recommendations for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.